NOAEL Studies
Cosmetic Ingredient
2-Hydroxyethyl Picramic Acid NOAEL Studies
INCI: 2-HYDROXYETHYL PICRAMIC ACID
CAS: 99610-72-7
Raw No Observed Adverse Effect Level endpoint records grouped by source. This page does not render calculated Margin of Safety values.
COSMOS DB 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| COSMOS DB | LOAEL | 20 | mg/kg bw/day | rat | oral | 91 day | Subchronic | SCCP; Weide, J.; 3-monatige Toxizitätsprüfung an Ratten mit der Testsubstanz Pikraminrot;WELLA AG; 1985 |
SCCS Opinion 10 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| SCCS Opinion | NOAEL | =0.13 | mg/kg bw | rat | oral | 90-day | dermal absorption | p.27 |
| SCCS Opinion | NOAEL | =0.16 | mg/kg bw | rat | oral | 90-day | dermal absorption | p.26 |
| SCCS Opinion | NOAEL | =15 | mg/kg bw | rat | - | Chronic | genotoxicity | p.18 |
| SCCS Opinion | NOAEL | =20 | mg/kg bw | rat | - | - | NOAEL study | p.17 |
| SCCS Opinion | NOAEL | =20 | mg/kg bw/day | rat | - | 90 days | reproductive toxicity | p.27 |
| SCCS Opinion | NOAEL | =50 | mg/kg bw | - | oral | Sub-chronic | repeated dose toxicity | Ref.: 13 (submission I) 3, p.17 |
| SCCS Opinion | NOAEL | =50 | mg/kg bw/day | human | - | 12 to day | NOAEL study | p.25 |
| SCCS Opinion | NOAEL | =60 | mg/kg bw | rat | - | 90 days | reproductive toxicity | p.27 |
| SCCS Opinion | NOAEL | =120 | mg/kg bw/day | rat | oral | 28-day | reproductive toxicity | p.25 |
| SCCS Opinion | NOAEL | =120 | mg/kg bw | rabbit | dermal | 28-day | reproductive toxicity | p.27 |
Regulatory source 13 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| Regulatory source | - | 20 | mg/kg bw | rat | - | - | - | p.17 |
| Regulatory source | - | 50 | mg/kg bw/day | human | - | 12 to day | - | p.25 |
| Regulatory source | dermal absorption | =0.13 | mg/kg bw | rat | oral | 90-day | dermal absorption | p.27 |
| Regulatory source | dermal absorption | =0.16 | mg/kg bw | rat | oral | 90-day | dermal absorption | p.26 |
| Regulatory source | dermal absorption | =20 | mg/kg bw | rat | oral | 90-day | dermal absorption | p.26 |
| Regulatory source | genotoxicity | 15 | mg/kg bw | rat | - | Chronic | genotoxicity | p.18 |
| Regulatory source | repeated dose toxicity | 50 | mg/kg bw | - | oral | Sub-chronic | repeated dose toxicity | p.17 |
| Regulatory source | reproductive toxicity | 20 | mg/kg bw/day | rat | - | 90 days | reproductive toxicity | p.27 |
| Regulatory source | reproductive toxicity | 50 | mg/kg bw/day | rat | - | 90 days | reproductive toxicity | p.27 |
| Regulatory source | reproductive toxicity | 60 | mg/kg bw | rat | - | 90 days | reproductive toxicity | p.27 |
| Regulatory source | reproductive toxicity | 120 | mg/kg bw/day | rat | oral | 28-day | reproductive toxicity | p.25 |
| Regulatory source | reproductive toxicity | 120 | mg/kg bw | rabbit | dermal | 28-day | reproductive toxicity | p.27 |
| Regulatory source | reproductive toxicity | 120 | mg/kg bw | rabbit | - | 28-day | reproductive toxicity | p.27 |
openFDA substances 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| openFDA substances | FDA UNII substance identifier | KZ27KOJ0GZ | UNII | - | - | - | chemical | - |